ABSCI CORPORATION - CO

Absci to Participate in the B. Riley Securities' Life Sciences Tools Conference - Proteomics Setting the Blueprint for Innovative Drug Creation

23 Mar 2023 08:00:00 By Nasdaq GlobeNewswire

Absci to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

07 Mar 2023 08:00:01 By Nasdaq GlobeNewswire

Absci Expands in Europe with Launch of New Innovation Center and Additional Senior Leadership in Switzerland

28 Feb 2023 08:00:01 By Nasdaq GlobeNewswire

Absci to Participate in the 43rd Annual Cowen Health Care Conference

21 Feb 2023 08:00:02 By Nasdaq GlobeNewswire

St. John’s Cancer Institute Partners with Absci to Expedite Development of Cancer Therapies

09 Feb 2023 08:00:01 By Nasdaq GlobeNewswire

Absci Deepens Scientific Advisory Board to Accelerate Generative AI Drug Creation

08 Feb 2023 08:00:00 By Nasdaq GlobeNewswire

Absci First to Create and Validate De Novo Antibodies with Zero-Shot Generative AI

10 Jan 2023 08:00:02 By Nasdaq GlobeNewswire

Absci to Participate in the 41st Annual J.P. Morgan Healthcare Conference

08 Jan 2023 15:13:30 By Nasdaq GlobeNewswire

Absci to Participate in the 41st Annual J.P. Morgan Healthcare Conference

28 Dec 2022 08:00:00 By Nasdaq GlobeNewswire

Absci to Participate in the Berenberg Discover AI Seminar

23 Nov 2022 08:00:00 By Nasdaq GlobeNewswire

Absci to Participate in the Stifel Healthcare Conference

02 Nov 2022 16:05:01 By Nasdaq GlobeNewswire

Absci Welcomes Meta Senior Executive to Board of Directors

02 Nov 2022 08:00:01 By Nasdaq GlobeNewswire

Absci to Participate in the 31st Annual Credit Suisse Healthcare Conference

26 Oct 2022 08:00:01 By Nasdaq GlobeNewswire

Absci Appoints Veteran Pharma Executive Andreas Busch, PhD as Chief Innovation Officer

04 Oct 2022 07:00:00 By Nasdaq GlobeNewswire

Absci to Participate in the Morgan Stanley Global Healthcare Conference

01 Sep 2022 08:00:01 By Nasdaq GlobeNewswire

Absci to Participate at the Inaugural Gilmartin Group Emerging Growth Company Showcase

24 Aug 2022 07:00:00 By Nasdaq GlobeNewswire

Absci Reports Second Quarter 2022 Financial Results and Business Update

11 Aug 2022 08:00:01 By Nasdaq GlobeNewswire

Absci to Participate in the SVB Securities CybeRx: Big Data, A.I. & Machine Learning in Healthcare Event

21 Jul 2022 07:00:00 By Nasdaq GlobeNewswire

Absci Prepares for Next Stage of Growth with Executive Human Resources and Marketing Hires

14 Jul 2022 07:05:00 By Nasdaq GlobeNewswire

Absci Enters Multi-Program Collaboration with Emerging Biotech Partner

07 Jul 2022 07:05:00 By Nasdaq GlobeNewswire